# The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients

> **NCT04405583** · — · RECRUITING · sponsor: **Occlutech International AB** · enrollment: 150 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Occlutech Atrial Flow Regulator

## Key facts

- **NCT ID:** NCT04405583
- **Lead sponsor:** Occlutech International AB
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2020-10-28
- **Primary completion:** 2027-06-30
- **Final completion:** 2027-10
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2026-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405583

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405583, "The AFteR Registry - Follow-up Study to Monitor the Efficacy and Safety of the Occlutech AFR in Heart Failure Patients". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT04405583. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*